🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
Aim and objectives: This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Start Date
2016-06-02
Trial ID
NCT02951325
Treatments Being Tested
The aim of the study is to determine if intervening with combined local the...
Status
Completed
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2019-02-01
Trial ID
NCT03904927
Treatments Being Tested
Patients with intrahepatic cholangiocarcinoma (IHC) have relatively aggress...
Status
Recruiting
Location
Oslo University Hospital
Start Date
2024-02-13
Trial ID
NCT06313203
Treatments Being Tested
Knee osteoarthritis (OA) is the most common form of arthritis and the most ...
Status
Completed
Location
The University of Nottingham, City Hospital Campus
Start Date
2020-11-06
Trial ID
NCT04443452
The goal of this clinical trial is to evaluate the efficacy of using SP-002...
Status
Recruiting
Location
Research Site
Start Date
2024-04-09
Trial ID
NCT06344052
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
The goal of this clinical trial is to learn whether new adjuvant radiothera...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-01
Trial ID
NCT07200141
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215